The Effect of Melatonin and Vitamin C on COVID-19

Not Applicable

Completed

• Conditions: Covid19; SARS-CoV Infection

• Registration Number: NCT04530539
• Lead Sponsor: Lancaster General Hospital

Brief Summary

This is a double-blind placebo controlled trial that seeks to evaluate the impact of melatonin and vitamin C on symptoms and outcomes of patients with COVID-19.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-08-26
• Study First Submitted QC: 2020-08-26
• Study First Posted: 2020-08-28
• Study Start: 2020-10-05
• Status Verified: 2022-08
• Primary Completion: 2022-08-11
• Study Completion: 2022-08-11
• Last Update Submitted: 2022-08-16
• Last Update Posted: 2022-08-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Symptom Severity	14 days	Symptom severity will be tracked electronically

Secondary Outcome Measures

Name	Time	Method
Symptom progression	14 days	Determine symptom course of those with moderate or severe symptoms

Trial Locations

Locations (1)

Lancaster General Health; 🇺🇸 Lancaster, Pennsylvania, United States